the aid library

LIST OPTIONS

Filter

6031

Sort by:

Direction:

Download (74)

View PDF (141)

Project Bridge: Differentiation of HIV Services for PWID in Harm Reduction Programs in Kazakhstan

Columbia Social Intervention Group; BRIGE; Consortium of Universities for Global Health; National Institute on Drug Abuse (2019) C2

Nabila El-Bassel, PhD Columbia University @NabilaElBassel #CUGH2018 Accessed: 26.09.2019

Download (121)

View PDF (120)

Oral pre-exposure prophylaxis - Putting a new choice in context

UNAIDS (Joint United Nations Programme on HIVAIDS); World Health Organization (WHO); Global Advocacy for HIV Prevention (AVAC) UNAIDS (Joint United Nations Programme on HIVAIDS); World Health Organization (WHO); Global Advocacy for HIV Prevention (AVAC) (2015) C2

Reference

Download (27)

View PDF (31)

Guidelines for the prevention, management and care of diabetes mellitus

World Health Organization WHO (2006) C_WHO

Diabetes mellitus is one of the most common noncommunicable diseases worldwide. In the Eastern Mediterranean Region there has been a rapid increase in the incidence of diabetes mellitus and it is now the fourth leading cause of death. The increasing prevalence of diabetes mellitus, the emergence of ... more

Download (271)

View PDF (365)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (135)

View PDF (140)

The COVAX facility

World Health Organization WHO (2020) C_WHO

Global procurement for COVID-19 vaccines

Download (100)

View PDF (100)

Sustainable financing: Report by the Director-General

World Health Organization (WHO) World Health Organization (WHO) (2021) CC

The biennium 2020–2021 has revealed more clearly than ever the need for a strong, credible and independent WHO on the world stage. The coronavirus disease (COVID-19) crisis has demonstrated the fundamental importance of the global detection, response and coordination roles that only WHO can play a... more

Download (487)

View PDF (966)

Depression and Other Common Mental Disorders
recommended

World Health Organization (WHO) (2017) C_WHO

This booklet provides latest available estimates of the prevalence of depression and other common mental disorders at the global and regional level, together with data concerning the consequences of these disorders in terms of lost health.

Download (189)

View PDF (222)

Our duty of care

Abdul Rahim, H.F.; M. Fendt-Newlin, S. T. Al-Harahsheh, et al. Quatar Foundation; Wolrd Innovation Summir ofr Health WISH (2022) CC

A global call to action to protect the mental health of health and care workers

Download (155)

View PDF (141)

Guidance for country validation of viral hepatitis elimination and path to elimination

World Health Organization WHO (2023) C_WHO

Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig... more

Download (34)

View PDF (47)

Country cooperation strategy for WHO and Syrian Arab Republic: 2022-2025

World Health Organization WHO (2024) C_WHO

WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s... more

Download (38)

View PDF (46)

Invisible numbers; The true extent of noncommunicable diseases and what to do about them 2022

World Health Organization (WHO) World Health Organization (WHO) (2022) C_WHO

Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental health, cause nearly three quarters of deaths in the world. Their drivers are social, environmental, commercial and geneti... more

Download (29)

View PDF (35)

Report - Invisible numbers: the true extent of noncommunicable diseases and what to do about them

World Health Organization (WHO) World Health Organization (WHO) (2022) C_WHO

Download (60)

View PDF (58)

From emergency response to long-term COVID-19 disease management - Ending the COVID-19 emergency and transitioning from emergency phase to longer-term disease management: Guidance on calibrating the r

World Health Organization WHO (2023) C_WHO

The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows: National action plan key activities, prioritized for the current context and the current ... more

Download (288)

View PDF (310)

Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030

World Health Organization WHO (2021) C_WHO

The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate progra... more

Download (222)

View PDF (251)

State of the world's hand hygiene

World Health Organisation (WHO) (2021) C_WHO

This report is the first of its kind. It brings together various data sets to present the current status of hand hygiene, highlight lagging progress, and call governments and supporting agencies to action, offering numerous inspiring examples of change. During the COVID-19 pandemic, hand hygiene ... more

Download (85)

View PDF (139)

Gender and COVID-19

World Health Organisation (2020) C_WHO

Pandemics and outbreaks have differential impacts on women and men. From risk of exposure and biological susceptibility to infection to the social and economic implications, individuals’ experiences are likely to vary according to their biological and gender characteristics and... more

Download (253)

View PDF (436)

State of the World’s Nursing Report - 2020

World Health Organization WHO (2020) C1

The State of the world’s nursing 2020 report provides the latest, most up-to-date evidence on and policy options for the global nursing workforce. It also presents a compelling case for considerable – yet feasible – investment in nursing education, jobs, and leadership. The primary chapters... more

Download (335)

View PDF (932)

Walking in our shoes: Perspectives of pregnant and breastfeeding women living with HIV on access to and retention in care in Malawi, Uganda and Zambia

Global Network of People Living with HIV (GNP+), International Community of Women Living with HIV (ICW) et al. (2017) C1

The study sought to understand the factors that facilitate women to adhere to treatment and return to health facilities for routine care from their own perspective. The researchers focused on Malawi, Uganda and Zambia, early adopters of the global guidance to provide lifelong treatment for pregnant ... more

Download (102)

View PDF (130)

Ecuador - Country Indicators Medical Devices

World Health Organization WHO (2014) C_WHO

Fact Sheet Global Atlas of medical devices

Download (200)

View PDF (173)

Considerations for developing a national genomic surveillance strategy or action plan for pathogens with pandemic and epidemic potential

World Health Organization WHO (2023) C_WHO

Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant... more

Depression and Other Common Mental Disorders recommended

Depression and Other Common Mental Disorders
recommended